Menu
Back to User profile » Dr Chengping Hu
Papers published by Dr Chengping Hu:
The Intrapleural Bridge Connection is One of the Reasons for Unknown Localized Pleural Adhesion
Gu Q, Deng X, Li Z, Wang J, Hu C, Lei S, Cai X
International Journal of General Medicine 2021, 14:1429-1435
Published Date: 20 April 2021
Poor prognosis of pulmonary sarcomatoid carcinoma with KRAS mutation and ALK fusion
Chen F, Gu Q, Hu C, Cai X, Lei S
OncoTargets and Therapy 2019, 12:3321-3325
Published Date: 1 May 2019
Epigallocatechin-3-gallate-induced vascular normalization in A549-cell xenograft-bearing nude mice: therapeutic efficacy in combination with chemotherapy
Deng P, Hu C, Xiong Z, Li Y, Jiang J, Yang H, Tang Y, Cao L, Lu R
Cancer Management and Research 2019, 11:2425-2439
Published Date: 27 March 2019
Newly emergent acquired EGFR exon 18 G724S mutation after resistance of a T790M specific EGFR inhibitor osimertinib in non-small-cell lung cancer: a case report
Zhang Y, He B, Zhou D, Li M, Hu C
OncoTargets and Therapy 2019, 12:51-56
Published Date: 18 December 2018
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial
Wu YL, Xu CR, Hu CP, Feng J, Lu S, Huang Y, Li W, Hou M, Shi JH, Märten A, Fan J, Peil B, Zhou C
OncoTargets and Therapy 2018, 11:8575-8587
Published Date: 30 November 2018
Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung
Lu S, Li W, Zhou C, Hu CP, Qin S, Cheng G, Feng J, Wang J, Cseh A, Peil B, Gibson N, Ehrnrooth E, Zhang L
OncoTargets and Therapy 2018, 11:8565-8573
Published Date: 30 November 2018
Recurrence risk after preoperative biopsy in patients with resected early-stage non-small-cell lung cancer: a retrospective study
Hu CP, Jiang J, Li YY, Zhang CF, Zhang WX, Jiang HH, Gao Y, Zhuang W, Lei KB, Tang Y, Wan RJ
Cancer Management and Research 2018, 10:1927-1934
Published Date: 6 July 2018
Real-world hospital costs for nonchemotherapy drugs and nondrug care associated with platinum-based doublets in the first-line setting for advanced nonsquamous non-small-cell lung cancer in Chinese patients: a retrospective cohort study
Chen JH, Wu S, Hu C, Yang Y, Rajan N, Chen Y, Yang C, Li J, Chen W
ClinicoEconomics and Outcomes Research 2016, 8:97-111
Published Date: 26 April 2016